Project
A phase IIIb multicenter, 52 week treatment, randomized, blinded, double dummy, parallel group efficacy study comparing the effect of inhaled indacaterol 150ug o.d. vs inhaled tiotropium 18ug o.d. on lung function, rate of exacerbations and related outcomes in patients with COPD
Completed ยท 2009 until 2011
Haider Karin, Burger Barbara, Brutsche Martin
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2009
End Date
2011
Financing
Industry
Study Design
Phase IIIb multicenter, 52 week treatment, randomized, blinded, double dummy, parallel group efficacy study
Keywords
Indacaterol, tiotropium, COPD